(19)
(11) EP 0 765 357 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.03.2006 Bulletin 2006/10

(45) Mention of the grant of the patent:
14.12.2005 Bulletin 2005/50

(21) Application number: 95921661.5

(22) Date of filing: 15.06.1995
(51) International Patent Classification (IPC): 
C08G 69/48(1974.07)
A61K 31/745(1985.01)
A61K 31/755(1985.01)
A61K 31/765(1985.01)
A61K 31/775(1985.01)
A61K 31/785(1985.01)
 A61K 31/74(1985.01)
A61K 31/75(1985.01)
A61K 31/76(1985.01)
A61K 31/77(1985.01)
A61K 31/78(1985.01)
(86) International application number:
PCT/AU1995/000350
(87) International publication number:
WO 1995/034595 (21.12.1995 Gazette 1995/54)

(54)

ANTIVIRAL DENDRIMERS

ANTIVIRALE DENDRIMERE

DENDRIMERES ANTIVIRAUX

(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 15.06.1994 AU PM623994

(43) Date of publication of application:
02.04.1997 Bulletin 1997/14

(73) Proprietor: Starpharma Pty Limited
Melbourne VIC (AU)

(72) Inventors:
  • MATTHEWS, Barry, Ross
    Olinda, VIC 3788 (AU)
  • HOLAN, George
    Brighton, VIC 3186 (AU)

(74) Representative: Nachshen, Neil Jacob et al
D Young & Co 120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)


(56) References cited: : 
EP-A- 0 328 403
WO-A-93/03766
AU-A- 2 435 484
AU-A- 7 715 987
 EP-A- 0 339 695
AU-A- 1 240 095
AU-A- 4 906 585
US-A- 5 229 490
   
  • JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL COMMUNICATIONS, (24), 93.00.00, 1869-72, ROY RENE; ZANINI DIANA; MEUNIER SERGE J.; ROMANOWSKA ANNA, "Solid-Phase Synthesis of Dendritic Sialoside Inhibitors of Influenza A Virus Hemagglutinin".
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).